Annoroad Awarded Patent of Rapid Testing of Numerical Abnormalities of Chromosomes
2014.09.15


Recently, Annoroad’s self-developed rapid testing technology of numerical abnormalities of chromosomes has been granted national patent for invention by State Intellectual Property Office of the PRC This technology is optimization and upgrading of second-generation sequencing technology. Its primer, reagent kit and testing method are protected by State Intellectual Property Office of the PRC.


This is a new testing method which is designed and developed according to the structural features of chromosome. Such method combines second-generation sequencing technology with up-to-date research findings of bioinformatics to bring the testing of numerical abnormalities of chromosomes higher precision, quicker speed and lower cost. Compared with existing technologies, under the circumstance of the same sequencing data size, this invention can reach higher sequencing depth, thus reducing the background noise during the subsequent data analysis greatly; shorten the time of creating library up to a half, thus enhancing testing efficiency; and reduce the testing cost due to the improvement of method.


Whether individual DNA or free DNA in the pregnant woman’s peripheral blood, such technology has apparent advantages in the testing of numerical abnormalities of chromosomes. Such technology can provide pregnant woman with more precision, more efficient, more economical non-invasive prenatal DNA testing, so it is conducive to wide popularization of the non-invasive prenatal DNA testing; therefore, it is of great significance to enhance the birth quality and prevent the birth defects.


Since its inception, Annoroad has been committed to independent R&D and innovation of transformation and application of genomics technology industry, and has obtained many qualifications and honors: “Clinical Molecular Cytogenetics Medical Testing Institution”, “Beijing Municipal Scientific Research and Development Institution”, “Zhongguancun High-tech Enterprise”, “Zhongguancun Top 10 Innovation Achievements”, etc., and many software copyrights. Such patent indicates that State Intellectual Property Office of the PRC highly affirms Annoroad’s scientific research and innovation ability. In future, Annoroad will create the first-rate brand in the spirit of independent innovation, and make greater contribution to people’s livelihood, with the genomics as its foundation, with information technology as its support. 


分享:
Good News! Annoroad Is Recognized as Beijing Intellectual Property Demonstration Organization
2019.08.02

Recently, the Beijing Municipal Intellectual Property Office announced the “Beijing Intellectual Property Pilot/Model Organization List”. Among the 45 “Beijing Intellectual Property Demonstration Organization” recognized, Annoroad is the only genomics enterprise, which fully demonstrates that Annoroad has become a leader in intellectual property in the genomics industry.


1.png


Recently, the Beijing Municipal Intellectual Property Office announced the “Beijing Intellectual Property Pilot/Model Organization List”. Among the 45 “Beijing Intellectual Property Demonstration Organization” recognized, Annoroad is the only genomics enterprise, which fully demonstrates that Annoroad has become a leader in intellectual property in the genomics industry.


2.png

Since its establishment in 2012, Annoroad has attached great importance to intellectual property work, and has carried out a series of work in the revision and planning of intellectual property regulations, personnel arrangements and training, application and protection, and achieved remarkable results. Annoroad has obtained more than 80 national intellectual property rights, and has been recognized as National High-tech Enterprise, Beijing Science and Technology Research and Development institution, Patent Pilot Organization, Precision Medical and Gene Engineering Research Institute, Youth Innovation Workstation, etc.The acquisition of this series of qualifications and honors fully reflects the overall strength of Annoroad in technological innovation and technology research and development.


In the future, Annoroad will play the role of demonstration of intellectual property rights demonstration organizations fully, continue to do a good job in intellectual property related work, focus on the application of intellectual property transformation and promotion, and contribute to further promote the development of gene test technology and clinical transformation applications.

分享:

Copyright © Annoroad Gene Technology 京ICP备12029022号-1